Research ArticleClinical Studies
Open Access

Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma

TORU ISHIKAWA, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA and TERASU HONMA
In Vivo September 2024, 38 (5) 2501-2505; DOI: https://doi.org/10.21873/invivo.13721

Article Figures & Data

Figures

  • Figure 1.
    Figure 1.

    Kaplan-Meier curve demonstrating overall survival of hepatocellular carcinoma with portal vein tumor thrombus after radiofrequency ablation.

  • Figure 2.
    Figure 2.

    Kaplan-Meier curve demonstrating overall survival of hepatocellular carcinoma with portal vein tumor thrombus after radiofrequency ablation in the transarterial chemoembolization (TACE) group and no-TACE group (p=0.0151). 0: No TACE group, 1: with TACE group.

  • Figure 3.
    Figure 3.

    Kaplan-Meier curve demonstrating overall survival of hepatocellular carcinoma with portal vein tumor thrombus after radiofrequency ablation in the esophagogastric variceal exacerbation group and in the non-exacerbation group (p=0.00964). 0: the non-exacerbation group, 1: esophagogastric variceal exacerbation group.

Tables

  • Table I.
  • Table II.
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Determinants of Survival of Ablation Treatment for Portal Vein Tumor Thrombus in Patients With Hepatocellular Carcinoma
TORU ISHIKAWA, RYO SATO, RYO JIMBO, YUJI KOBAYASHI, TOSHIFUMI SATO, AKITO IWANAGA, TOMOE SANO, JUNJI YOKOYAMA, TERASU HONMA
In Vivo Sep 2024, 38 (5) 2501-2505; DOI: 10.21873/invivo.13721
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords